Early results with the Pfizer (Cominarty) vaccine in cancer patients show it has poor immune efficacy after a single dose, highlighting the need for patients to receive the second dose as soon as possible. A prospective study involving 151 cancer patients in the UK found that three weeks following the first dose of mRNA-based SARS-CoV-2 ...
Cancer patients need two doses of COVID-19 vaccine for protection: study
By Michael Woodhead
28 Apr 2021